Literature DB >> 29777010

Developmental vascular regression is regulated by a Wnt/β-catenin, MYC and CDKN1A pathway that controls cell proliferation and cell death.

Gowri Nayak1,2,3,4, Yoshinobu Odaka1,2,3,4, Vikram Prasad5, Alyssa F Solano1,2,3,4, Eun-Jin Yeo1,2,3,4, Shruti Vemaraju1,2,3,4, Jeffery D Molkentin5,6, Andreas Trumpp7, Bart Williams8, Sujata Rao9,10, Richard A Lang11,2,3,4,5,12,13.   

Abstract

Normal development requires tight regulation of cell proliferation and cell death. Here, we have investigated these control mechanisms in the hyaloid vessels, a temporary vascular network in the mammalian eye that requires a Wnt/β-catenin response for scheduled regression. We investigated whether the hyaloid Wnt response was linked to the oncogene Myc, and the cyclin-dependent kinase inhibitor CDKN1A (P21), both established regulators of cell cycle progression and cell death. Our analysis showed that the Wnt pathway co-receptors LRP5 and LRP6 have overlapping activities that mediate the Wnt/β-catenin signaling in hyaloid vascular endothelial cells (VECs). We also showed that both Myc and Cdkn1a are downstream of the Wnt response and are required for hyaloid regression but for different reasons. Conditional deletion of Myc in VECs suppressed both proliferation and cell death. By contrast, conditional deletion of Cdkn1a resulted in VEC overproliferation that countered the effects of cell death on regression. When combined with analysis of MYC and CDKN1A protein levels, this analysis suggests that a Wnt/β-catenin and MYC-CDKN1A pathway regulates scheduled hyaloid vessel regression.
© 2018. Published by The Company of Biologists Ltd.

Entities:  

Keywords:  CDKN1A; Endothelial cell; Hyaloid; MYC; P21; Vascular regression; Wnt signaling

Mesh:

Substances:

Year:  2018        PMID: 29777010      PMCID: PMC6031408          DOI: 10.1242/dev.154898

Source DB:  PubMed          Journal:  Development        ISSN: 0950-1991            Impact factor:   6.868


  90 in total

1.  Obligatory participation of macrophages in an angiopoietin 2-mediated cell death switch.

Authors:  Sujata Rao; Ivan B Lobov; Jefferson E Vallance; Kaoru Tsujikawa; Ichiro Shiojima; Shailaja Akunuru; Kenneth Walsh; Laura E Benjamin; Richard A Lang
Journal:  Development       Date:  2007-12       Impact factor: 6.868

2.  Role of nucleotide sequences of loxP spacer region in Cre-mediated recombination.

Authors:  G Lee; I Saito
Journal:  Gene       Date:  1998-08-17       Impact factor: 3.688

3.  LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development.

Authors:  Y Gong; R B Slee; N Fukai; G Rawadi; S Roman-Roman; A M Reginato; H Wang; T Cundy; F H Glorieux; D Lev; M Zacharin; K Oexle; J Marcelino; W Suwairi; S Heeger; G Sabatakos; S Apte; W N Adkins; J Allgrove; M Arslan-Kirchner; J A Batch; P Beighton; G C Black; R G Boles; L M Boon; C Borrone; H G Brunner; G F Carle; B Dallapiccola; A De Paepe; B Floege; M L Halfhide; B Hall; R C Hennekam; T Hirose; A Jans; H Jüppner; C A Kim; K Keppler-Noreuil; A Kohlschuetter; D LaCombe; M Lambert; E Lemyre; T Letteboer; L Peltonen; R S Ramesar; M Romanengo; H Somer; E Steichen-Gersdorf; B Steinmann; B Sullivan; A Superti-Furga; W Swoboda; M J van den Boogaard; W Van Hul; M Vikkula; M Votruba; B Zabel; T Garcia; R Baron; B R Olsen; M L Warman
Journal:  Cell       Date:  2001-11-16       Impact factor: 41.582

4.  c-Myc regulates mammalian body size by controlling cell number but not cell size.

Authors:  A Trumpp; Y Refaeli; T Oskarsson; S Gasser; M Murphy; G R Martin; J M Bishop
Journal:  Nature       Date:  2001-12-13       Impact factor: 49.962

5.  Further evidence of genetic heterogeneity in familial exudative vitreoretinopathy; exclusion of EVR1, EVR3, and EVR4 in a large autosomal dominant pedigree.

Authors:  C Toomes; L M Downey; H M Bottomley; H A Mintz-Hittner; C F Inglehearn
Journal:  Br J Ophthalmol       Date:  2005-02       Impact factor: 4.638

6.  Endothelial cell-derived non-canonical Wnt ligands control vascular pruning in angiogenesis.

Authors:  Claudia Korn; Beate Scholz; Junhao Hu; Kshitij Srivastava; Jessica Wojtarowicz; Tabea Arnsperger; Ralf H Adams; Michael Boutros; Hellmut G Augustin; Iris Augustin
Journal:  Development       Date:  2014-04       Impact factor: 6.868

7.  Identification of c-MYC as a target of the APC pathway.

Authors:  T C He; A B Sparks; C Rago; H Hermeking; L Zawel; L T da Costa; P J Morin; B Vogelstein; K W Kinzler
Journal:  Science       Date:  1998-09-04       Impact factor: 47.728

Review 8.  Apoptotic signaling by c-MYC.

Authors:  B Hoffman; D A Liebermann
Journal:  Oncogene       Date:  2008-10-27       Impact factor: 9.867

Review 9.  Mechanisms of c-myc-mediated transcriptional repression of growth arrest genes.

Authors:  Andrei L Gartel; Ksenya Shchors
Journal:  Exp Cell Res       Date:  2003-02-01       Impact factor: 3.905

10.  A relationship between apoptosis and flow during programmed capillary regression is revealed by vital analysis.

Authors:  A Meeson; M Palmer; M Calfon; R Lang
Journal:  Development       Date:  1996-12       Impact factor: 6.868

View more
  11 in total

Review 1.  Wnt Signaling in vascular eye diseases.

Authors:  Zhongxiao Wang; Chi-Hsiu Liu; Shuo Huang; Jing Chen
Journal:  Prog Retin Eye Res       Date:  2018-12-01       Impact factor: 21.198

2.  MYC Participates in Lipopolysaccharide-Induced Sepsis via Promoting Cell Proliferation and Inhibiting Apoptosis.

Authors:  Yin Li; C Hengqi Kong; Lei Feng; Wenliang Tang; Mengwei Chen; Zhiyuan Zheng
Journal:  Cell J       Date:  2020-07-18       Impact factor: 2.479

3.  An inhibitor of endothelial ETS transcription factors promotes physiologic and therapeutic vessel regression.

Authors:  Christopher M Schafer; Jami M Gurley; Katarzyna Kurylowicz; Prisca K Lin; Wen Chen; Michael H Elliott; George E Davis; Faizah Bhatti; Courtney T Griffin
Journal:  Proc Natl Acad Sci U S A       Date:  2020-10-05       Impact factor: 11.205

4.  The transcription factor Maz is essential for normal eye development.

Authors:  Olga Medina-Martinez; Meade Haller; Jill A Rosenfeld; Marisol A O'Neill; Dolores J Lamb; Milan Jamrich
Journal:  Dis Model Mech       Date:  2020-08-18       Impact factor: 5.758

5.  Aberrant MFN2 transcription facilitates homocysteine-induced VSMCs proliferation via the increased binding of c-Myc to DNMT1 in atherosclerosis.

Authors:  Long Xu; Hongyi Hao; Yinju Hao; Guo Wei; Guizhong Li; Pengjun Ma; Lingbo Xu; Ning Ding; Shengchao Ma; Alex F Chen; Yideng Jiang
Journal:  J Cell Mol Med       Date:  2019-05-18       Impact factor: 5.310

6.  Comparative Transcriptomics Reveals the Key lncRNA and mRNA of Sunite Sheep Adrenal Gland Affecting Seasonal Reproduction.

Authors:  Xiaolong Du; Xiaoyun He; Qiuyue Liu; Ran Di; Qingqing Liu; Mingxing Chu
Journal:  Front Vet Sci       Date:  2022-04-08

7.  In vivo imaging of the hyaloid vascular regression and retinal and choroidal vascular development in rat eyes using optical coherence tomography angiography.

Authors:  Yongjoo Kim; Jang Ryul Park; Hye Kyoung Hong; Myounghee Han; Jingu Lee; Pilhan Kim; Se Joon Woo; Kyu Hyung Park; Wang-Yuhl Oh
Journal:  Sci Rep       Date:  2020-07-30       Impact factor: 4.379

8.  Wnt Activation After Inhibition Restores Trabecular Meshwork Cells Toward a Normal Phenotype.

Authors:  Kamesh Dhamodaran; Hasna Baidouri; Lyndsey Sandoval; VijayKrishna Raghunathan
Journal:  Invest Ophthalmol Vis Sci       Date:  2020-06-03       Impact factor: 4.799

9.  TERT Promoter Revertant Mutation Inhibits Melanoma Growth through Intrinsic Apoptosis.

Authors:  Yanbing Wang; Yiwu Chen; Chang Li; Zhiwei Xiao; Hongming Yuan; Yuanzhu Zhang; Daxin Pang; Xiaochun Tang; Mengjing Li; Hongsheng Ouyang
Journal:  Biology (Basel)       Date:  2022-01-14

10.  Post-myocardial infarction heart failure dysregulates the bone vascular niche.

Authors:  Jedrzej Hoffmann; Guillermo Luxán; Wesley Tyler Abplanalp; Simone-Franziska Glaser; Tina Rasper; Ariane Fischer; Marion Muhly-Reinholz; Michael Potente; Birgit Assmus; David John; Andreas Michael Zeiher; Stefanie Dimmeler
Journal:  Nat Commun       Date:  2021-06-25       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.